Prosecution Insights
Prosecution Insights
8 pending office actions • 4 clients • 8 examiners • 7 art units • 0 of 8 (0%) have an AI response strategy ready • 23 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (38%) |
| §103 only | 2 (25%) |
| Multi-statute (no §101) | 3 (38%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WOOLWINE, SAMUEL C | 1 | 60.9% | +20.4% |
| WALLENHORST, MAUREEN | 1 | 78.9% | +5.6% |
| SODERQUIST, ARLEN | 1 | 59.8% | +26.5% |
| FLINDERS, JEREMY C | 1 | 63.9% | +16.4% |
| GUSSOW, ANNE | 1 | 58.0% | +42.6% |
| MARTIN, PAUL C | 1 | 41.8% | +21.7% |
| IVICH, FERNANDO NMN | 1 | 44.1% | +71.5% |
| HAYES, JONATHAN EDWARD | 1 | 37.5% | +23.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17942927 | METHODS FOR DETECTING DNA MUTATIONS USING MITRA TIP EXTRACTION | FLINDERS, JEREMY C | 31d overdue |
| 17610044 | MULTIPLEX ASSAY FOR DETERMINING THE ß-AMYLOID 42/40 RATIO IN HUMAN PLASMA SPECIMENS | IVICH, FERNANDO NMN | 22d overdue |
| 17977976 | METHODS FOR QUANTITATION OF INSULIN LEVELS BY MASS SPECTROMETRY | SODERQUIST, ARLEN | 1d overdue |
| 17892804 | CIRCULATING MICRORNA AS A MARKER FOR HEPATOCELLULAR CARCINOMA | GUSSOW, ANNE | 55d |
| 18288540 | WARNING SYSTEM FOR A DECAPPING/CAPPING SYSTEM | WALLENHORST, MAUREEN | — |
| 17006360 | PATHOGENICITY SCORING SYSTEM FOR HUMAN CLINICAL GENETICS | HAYES, JONATHAN EDWARD | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17942927 | METHODS FOR DETECTING DNA MUTATIONS USING MITRA TIP EXTRACTION | FLINDERS, JEREMY C | 31d overdue |
| 17610044 | MULTIPLEX ASSAY FOR DETERMINING THE ß-AMYLOID 42/40 RATIO IN HUMAN PLASMA SPECIMENS | IVICH, FERNANDO NMN | 22d overdue |
| 17977976 | METHODS FOR QUANTITATION OF INSULIN LEVELS BY MASS SPECTROMETRY | SODERQUIST, ARLEN | 1d overdue |
| 17892804 | CIRCULATING MICRORNA AS A MARKER FOR HEPATOCELLULAR CARCINOMA | GUSSOW, ANNE | 55d |
| 18794356 | METHODS FOR THE DIAGNOSIS OF BACTERIAL VAGINOSIS | WOOLWINE, SAMUEL C | — |
| 17588925 | Lp-PLA2 ASSAYS AND COMPOSITION WITH DETERGENT | MARTIN, PAUL C | — |
| 17006360 | PATHOGENICITY SCORING SYSTEM FOR HUMAN CLINICAL GENETICS | HAYES, JONATHAN EDWARD | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Quest Diagnostics | 5 |
| Quest Diagnostics Investments LLC | 1 |
| CLEVELAND HEARTLAB, INC. | 1 |
| Athena Diagnostics | 1 |
| Art Unit | Apps |
|---|---|
| 1797 | 2 |
| 1681 | 1 |
| 1684 | 1 |
| 1683 | 1 |
| 1653 | 1 |
| 1678 | 1 |
| 1685 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18794356 | METHODS FOR THE DIAGNOSIS OF BACTERIAL VAGINOSIS | Quest Diagnostics Investments LLC | WOOLWINE, SAMUEL C | 1681 | §103 | Final Rejection | — | Pending | Aug 05, 2024 |
| 18288540 | WARNING SYSTEM FOR A DECAPPING/CAPPING SYSTEM | Quest Diagnostics Investments LLC | WALLENHORST, MAUREEN | 1797 | §102§103§112 | Non-Final OA | — | Pending | Oct 26, 2023 |
| 17977976 | METHODS FOR QUANTITATION OF INSULIN LEVELS BY MASS SPECTROMETRY | Quest Diagnostics Investments LLC | SODERQUIST, ARLEN | 1797 | §102§103§112 | Non-Final OA | 1d overdue | Pending | Oct 31, 2022 |
| 17942927 | METHODS FOR DETECTING DNA MUTATIONS USING MITRA TIP EXTRACTION | Quest Diagnostics Investments LLC | FLINDERS, JEREMY C | 1684 | §103§112 | Final Rejection | 31d overdue | Pending | Sep 12, 2022 |
| 17892804 | CIRCULATING MICRORNA AS A MARKER FOR HEPATOCELLULAR CARCINOMA | Quest Diagnostics Investments LLC | GUSSOW, ANNE | 1683 | §101§103 | Non-Final OA | 55d | Pending | Aug 22, 2022 |
| 17588925 | Lp-PLA2 ASSAYS AND COMPOSITION WITH DETERGENT | Cleveland Heartlab, Inc. | MARTIN, PAUL C | 1653 | §103 | Final Rejection | — | Pending | Jan 31, 2022 |
| 17610044 | MULTIPLEX ASSAY FOR DETERMINING THE ß-AMYLOID 42/40 RATIO IN HUMAN PLASMA SPECIMENS | Quest Diagnostics Investments LLC | IVICH, FERNANDO NMN | 1678 | §101§112 | Non-Final OA | 22d overdue | Pending | Nov 09, 2021 |
| 17006360 | PATHOGENICITY SCORING SYSTEM FOR HUMAN CLINICAL GENETICS | Athena Diagnostics, Inc. | HAYES, JONATHAN EDWARD | 1685 | §101§112 | Non-Final OA | — | Pending | Aug 28, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial